2022-07-04-世界卫生组织-COVID-19_Vaccine_Implementation_Analysis_Insights_-_5_July_2022_53页_6mb

报告摘要

COVID-19 Vaccine Implementation Analysis & Insights Summary (July 5, 2022)

This report is produced by the COVID-19 Vaccine Delivery Partnership (CoVDP) and analyzes key implementation data for COVID-19 vaccines across the COVAX AMC portfolio and CoVDP-supported countries. The report covers daily vaccination rates, population coverage, supply secured and received, product utilization, and delivery financing.

Key Data Sources: Includes COVAX Demand and Supply Planning Mechanism data, IMF-WHO vaccine supply tracker, UN DESA population data, UNICEF financial and market dashboards, WHO/UNICEF electronic Joint Reporting Form, and WHO weekly vaccination data.
Methodology: Based on the CoVDP Data & Monitoring Coordination Manual.
Analytical Scope: Divided into two parts—AMC92 portfolio analysis and Concerted Support countries analysis—each examining: (a) summary, (b) daily vaccination rate, (c) population coverage, (d) supply secured and received, (e) product utilization, and (f) delivery financing.
Defined Terms:
- Course: Number of doses required for a primary vaccine series.
- Population coverage: Percentage of the total population fully vaccinated with any source vaccine.
- Product utilization: Percentage of received vaccine doses that have been used.
- Daily vaccination rate: Number of doses administered per unit time based on historical data.
Disclaimer: Data from reliable sources but not guaranteed to be current or accurate. No warranty or legal liability is assumed for data quality or usage.